Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 14, Number 5—May 2008

Perspective

Scale-up of Multidrug-Resistant Tuberculosis Laboratory Services, Peru

Sonya S. Shin*Comments to Author , Martin Yagui†, Luis Ascencios†, Gloria Yale‡, Carmen Suarez‡, Neyda Quispe†, Cesar Bonilla‡, Joaquin Blaya§, Allison Taylor¶, Carmen Contreras#, and Peter Cegielski¶
Author affiliations: *Brigham and Women’s Hospital, Boston, Massachusetts, USA; †Instituto Nacional de Salud, Lima, Peru; ‡Programa de Control de Tuberculosis, Lima, Peru; §Partners in Health, Boston, Massachusetts, USA; ¶Centers for Disease Control and Prevention, Atlanta, Georgia, USA; #Socios en Salud, Lima, Peru;

Main Article

Table 6

Automated reports generated by tuberculosis (TB) laboratory information system, Peru*

Report Informed Purpose Type of access†
Frequency of information system access by healthcare center personnel Regional laboratory and TB director Maintain frequent use of information system to access real-time laboratory data Monthly report prepared by data administrator
No. laboratory results entered at regional laboratory Regional laboratory and TB director Identify delays in data entry Monthly report prepared by data administrator
No. laboratory results verified and released to providers Regional laboratory and TB director Identify delays lags in result verification Monthly report prepared by data administrator
DST results for any specified period grouped by every variable in request form Regional and INS laboratory director Report and identify trends in laboratory performance Constant
Culture results for any specified period grouped by every variable in request form Regional and INS laboratory director Report and identify trends in laboratory performance Constant
DST and cultures in process too long, DST missing reception date, DSTs needed to be entered into system, duplicate tests Regional and INS laboratory director Quality control Constant
Rate of culture contamination; rate of negative culture growth from smear-positive specimens Regional and INS laboratory director Identify trends in laboratory performance Constant
Persons with a positive culture for any specified date Regional and INS laboratory director Reporting to regional TB program Constant
Persons with new DST or culture results Healthcare center personnel Minimize turnaround time of laboratory results Constant and email notification
Tests that are in process and the number of days in process Healthcare center personnel Inform personnel of when to expect results Constant

*DST, drug susceptibility testing; INS, Instituto Nacional de Salud.
†Constant access indicates that laboratory users could view this information in the system at any time. Some reports let the user specify the start and end dates.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO